Alison J. Moskowitz

Also affiliated with Cornell University, Kettering University, Lymphoma Research Foundation

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 31 papers. Top paper: “A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas”.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

Blood(2021)10.1182/blood.2021013379

N/A

4.9DataRank · unranked

180 citations

Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz, Sarah Noor +31 more

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.006

N/A

1.3DataRank · unranked

29 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Multicenter Phase 2 Study of Oral azacitidine (CC-486) plus CHOP as initial treatment for peripheral T-cell lymphoma

Blood(2023)10.1182/blood.2022018254

N/A

1.3DataRank · unranked

46 citations

Alison J. Moskowitz, Neha Mehta–Shah, Lubomir Sokol, Zhengming Chen, Nikita Kotlov +19 more

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2183

N/A

0.850DataRank · unranked

22 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024014263

N/A

0.113DataRank · unranked

1 citations

Parastoo B. Dahi, Farhad Khimani, Andrei R. Shustov, Mazyar Shadman, Jia Ruan +19 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma

British Journal of Haematology(2023)10.1111/bjh.19178

N/A

0DataRank · unranked

7 citations

Ariela Noy, Santosha A. Vardhana, Andrew D. Zelenetz, Alison J. Moskowitz, Robert Stuver

Osteonecrosis of the jaw associated with pembrolizumab

Oral Surgery Oral Medicine Oral Pathology and Oral Radiology(2023)10.1016/j.oooo.2022.12.013

N/A

0DataRank · unranked

14 citations

Alison J. Moskowitz, Gunjan L. Shah, Cherry L. Estilo, Joseph M. Huryn, SaeHee K. Yom +1 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Data from Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

(2023)10.1158/1078-0432.c.6530889.v1

N/A

0DataRank · unranked

0 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Cutaneous T‐cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes

Journal of the European Academy of Dermatology and Venereology(2024)10.1111/jdv.20141

N/A

0DataRank · unranked

16 citations

Stephen W. Dusza, Zachary D. Epstein‐Peterson, Paola Ghione, Sarah McCue Horwitz, W. Thomas Johnson +5 more

Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score–matched analysis

Blood Advances(2024)10.1182/bloodadvances.2023012145

N/A

0DataRank · unranked

9 citations

Fer de Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. LaCasce, Peter D. Cole +12 more

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis

Haematologica(2024)10.3324/haematol.2023.284179

N/A

0DataRank · unranked

8 citations

Zachary D. Epstein‐Peterson, Nivetha Ganesan, Timothy Pak, Tiffany Chang, Phuong Dao +21 more

Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas

Haematologica(2024)10.3324/haematol.2024.285183

N/A

0DataRank · unranked

3 citations

Kseniya Petrova‐Drus, Rohan Sardana, Sarah Huet, Qi Gao, Shenon Sethi +9 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

BEAM versus pharmacokinetics‐directed BuCyVP16 conditioning for patients with peripheral T‐cell lymphoma undergoing high‐dose therapy with autologous hematopoietic cell transplantation

American Journal of Hematology(2024)10.1002/ajh.27291

N/A

0DataRank · unranked

1 citations

Agrima Mian, Samantha Brown, Sean M. Devlin, Paolo F. Caimi, Stephanie Chinapen +14 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series

The Oncologist(2025)10.1093/oncolo/oyaf208

N/A

0DataRank · unranked

12 citations

Andrea P. Moy, Stephen W. Dusza, Alison J. Moskowitz, Gopa Iyer, Afsheen N. Iqbal +8 more

Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World Cohort

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.08.008

N/A

0DataRank · unranked

4 citations

Robert Stuver, Stephen W. Dusza, Zachary D. Epstein‐Peterson, Paola Ghione, Sarah McCue Horwitz +6 more

Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience

The Journal of Dermatology(2025)10.1111/1346-8138.17747

N/A

0DataRank · unranked

3 citations

Leore Lavin, Michael M Ong, Melissa Pulitzer, Alison J. Moskowitz, Patricia L. Myskowski +2 more

Dermatologic Adverse Events in Patients Receiving Duvelisib Single-Agent and Combination Therapies

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.07.011

N/A

0DataRank · unranked

2 citations

Nivetha Ganesan, Stephen W. Dusza, Steven M. Horwitz, Alison J. Moskowitz, Shamir Geller +1 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas

Haematologica(2025)10.3324/haematol.2025.288615

N/A

0DataRank · unranked

1 citations

Mingfei Yan, Nivetha Ganesan, Tiffany Chang, Ahmet Doǧan, Zachary D. Epstein‐Peterson +11 more

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Blood Cancer Journal(2020)10.1038/s41408-020-00340-z

N/A

0DataRank · unranked

203 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

120 | DETECTION OF INTRATUMORAL MICROORGANISMS AND THEIR IMPACT ON OUTCOMES IN UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_120

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Teng Fei, Ticiane Henriques Santa Rita, A. Rivas Delgado, Annie Qiu +31 more

Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms

Blood Advances(2020)10.1182/bloodadvances.2020001636

N/A

0DataRank · unranked

111 citations

Kseniya Petrova‐Drus, Sarah Huet, Zachary D. Epstein‐Peterson, Qi Gao, Allison E. Sigler +12 more

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002396

N/A

0DataRank · unranked

96 citations

Promie Faruque, Neha Mehta–Shah, Venkatraman Seshan, Neval Özkaya, Shakthi Bhaskar +15 more

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma

Blood Cancer Journal(2020)10.1038/s41408-020-0301-x

N/A

0DataRank · unranked

18 citations

Qi Gao, Neval Özkaya, Sarah Huet, Natasha Lewis, Janine Pichardo +5 more

Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.09.003

N/A

0DataRank · unranked

34 citations

Stacie Hudgens, Sarah McCue Horwitz, Pietro Quaglino, Richard Cowan, Larisa J. Geskin +14 more

PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome

Cytometry Part B Clinical Cytometry(2022)10.1002/cyto.b.22070

N/A

0DataRank · unranked

10 citations

Qi Gao, Kseniya Petrova‐Drus, Melissa Pulitzer, Allison Sigler, Jeeyeon Baik +5 more